162 related articles for article (PubMed ID: 16522526)
21. Serum resistin levels in women taking combined oral contraceptives containing desogestrel or gestodene.
Rechberger T; Tomaszewski J; Pieprzowska-Białek A; Kulik-Rechberger B; Skorupski P
Contraception; 2004 Jun; 69(6):477-80. PubMed ID: 15157792
[TBL] [Abstract][Full Text] [Related]
22. Investigation of the hemostatic effect of a transdermal patch containing 0.55 mg ethinyl estradiol and 2.1 mg gestodene compared with a monophasic oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel: an open-label, randomized, crossover study.
Junge W; Heger-Mahn D; Trummer D; Merz M
Drugs R D; 2013 Sep; 13(3):223-33. PubMed ID: 24043457
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
[TBL] [Abstract][Full Text] [Related]
24. [Effect of the monophase oral contraceptive combination with 20 ug ethinyl estradiol/150 ug desogestrel on haemostasis].
Uchikova E; Milchev N; Terzhumanov R; Markova D
Akush Ginekol (Sofiia); 2004; 43(4):29-32. PubMed ID: 15318540
[TBL] [Abstract][Full Text] [Related]
25. Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables.
Kluft C; Meijer P; LaGuardia KD; Fisher AC
Contraception; 2008 Feb; 77(2):77-83. PubMed ID: 18226669
[TBL] [Abstract][Full Text] [Related]
26. Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2.
Granfors MT; Backman JT; Laitila J; Neuvonen PJ
Clin Pharmacol Ther; 2005 Oct; 78(4):400-11. PubMed ID: 16198659
[TBL] [Abstract][Full Text] [Related]
27. Short-term effect of oral contraceptive pills on some haemostatic parameters in healthy Nigerian women.
Babatunde AS; Olatunji PO
Niger Postgrad Med J; 2004 Dec; 11(4):246-50. PubMed ID: 15627149
[TBL] [Abstract][Full Text] [Related]
28. Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial.
Johnson JV; Lowell J; Badger GJ; Rosing J; Tchaikovski S; Cushman M
Obstet Gynecol; 2008 Feb; 111(2 Pt 1):278-84. PubMed ID: 18238963
[TBL] [Abstract][Full Text] [Related]
29. The contraceptive vaginal ring (NuvaRing) and hemostasis: a comparative study.
Magnusdóttir EM; Bjarnadóttir RI; Onundarson PT; Gudmundsdóttir BR; Geirsson RT; Magnusdóttir SD; Dieben TO
Contraception; 2004 Jun; 69(6):461-7. PubMed ID: 15157790
[TBL] [Abstract][Full Text] [Related]
30. Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables.
Rad M; Kluft C; Ménard J; Burggraaf J; de Kam ML; Meijer P; Sivin I; Sitruk-Ware RL
Am J Obstet Gynecol; 2006 Jul; 195(1):72-7. PubMed ID: 16545330
[TBL] [Abstract][Full Text] [Related]
31. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of lipid profile in adolescents during long-term use of combined oral hormonal contraceptives.
Guazzelli CA; Lindsey PC; de Araújo FF; Barbieri M; Petta CA; Aldrighi JM
Contraception; 2005 Feb; 71(2):118-21. PubMed ID: 15707561
[TBL] [Abstract][Full Text] [Related]
33. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
Sabra A; Bonnar J
J Reprod Med; 1983 Jan; 28(1 Suppl):85-91. PubMed ID: 6834350
[TBL] [Abstract][Full Text] [Related]
34. Activation of coagulation in smoking and non-smoking women using a third-generation oral contraceptive containing desogestrel.
Fruzzetti F; De Negri F; Morale M; Ricci C; Ferrini L; Bersi C; Genazzani AR; Carmassi F
Eur J Contracept Reprod Health Care; 1999 Sep; 4(3):113-8. PubMed ID: 10574636
[TBL] [Abstract][Full Text] [Related]
35. A 1-year study to compare the hemostatic effects of oral contraceptive containing 20 microg of ethinylestradiol and 100 microg of levonorgestrel with 30 microg of ethinylestradiol and 100 microg of levonorgestrel.
Jespersen J; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Sidelmann JJ; Skouby SO
Contraception; 2005 Aug; 72(2):98-104. PubMed ID: 16022847
[TBL] [Abstract][Full Text] [Related]
36. Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel.
Prasad RN; Koh SC; Viegas OA; Ratnam SS
Clin Appl Thromb Hemost; 1999 Jan; 5(1):60-70. PubMed ID: 10725985
[TBL] [Abstract][Full Text] [Related]
37. Effects of long-term gestodene-containing oral contraceptive administration on hemostasis.
Abbate R; Pinto S; Rostagno C; Bruni V; Rosati D; Mariani G
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):424-9. PubMed ID: 2372036
[TBL] [Abstract][Full Text] [Related]
38. A comparison between effects of estradiol valerate and low dose ethinyl estradiol on haemostasis parameters.
Lindberg UB; Crona N; Stigendal L; Teger-Nilsson AC; Silfverstolpe G
Thromb Haemost; 1989 Feb; 61(1):65-9. PubMed ID: 2526387
[TBL] [Abstract][Full Text] [Related]
39. Hormone replacement therapy and hemostasis: effects in Brazilian postmenopausal women.
Callejon DR; Franceschini SA; Montes MB; Toloi MR
Maturitas; 2005; 52(3-4):249-55. PubMed ID: 16257613
[TBL] [Abstract][Full Text] [Related]
40. Effect of a low-dose ethinylestradiol and gestodene in combination on the frequency of micronuclei in human peripheral blood lymphocytes of healthy women in vivo.
Loncar D; Milosević-Djordjević O; Zivanović A; Grujicić D; Arsenijević S
Contraception; 2004 Apr; 69(4):327-31. PubMed ID: 15033409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
